Case Study: PET Imaging with Amyvid for Alzheimer’s
Video: Roberto Soto, MD, of Precision Imaging, shows a recent PET imaging case using Amyvid, recently approved for evaluation of Alzheimer's.
Roberto Soto, MD, founder and medical officer of Precision Imaging, shows a recent PET imaging case using Amyvid. The radioactive diagnostic agent Amyvid, or florbetapir, was FDA-approved in April for use in the evaluation of Alzheimer’s disease.
In this case, the patient also had an MRI, as seen in the top row. The studies were fused to show additional information. This is a negative Amyvid case, meaning no amyloid plaque was detected and there was a reduced likelihood the impairment is due to Alzheimer’s.
Study Examines CT-Based AI Detection of Incidental Abdominal Aortic Aneurysms
April 29th 2025The AI software Viz AAA offered a sensitivity of 87.5 percent in detecting abdominal aortic aneurysms on contrast-enhanced CT, according to new retrospective research presented at the American Roentgen Ray Society (ARRS) conference.
